Literature DB >> 10898175

Study of the inclusion complex of atenolol with beta-cyclodextrins.

R Ficarra1, P Ficarra, M R Di Bella, D Raneri, S Tommasini, M L Calabrò, A Villari, S Coppolino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10898175     DOI： 10.1016/s0731-7085(00)00274-0

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN： 0731-7085            Impact factor:   3.935


× No keyword cloud information.
  5 in total

Review 1.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

2.  Physicochemical properties and dissolution studies of dexamethasone acetate-beta-cyclodextrin inclusion complexes produced by different methods.

Authors:  Mayara M Doile; Keila A Fortunato; Iára C Schmücker; Sacha K Schucko; Marcos A S Silva; Patrik O Rodrigues
Journal:  AAPS PharmSciTech       Date:  2008-02-05       Impact factor: 3.246

3.  Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes.

Authors:  Fengwei Ai; Yingli Ma; Jiayu Wang; Yanfeng Li
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

4.  Biotinylated Cyclooligosaccharides for Paclitaxel Solubilization.

Authors:  Eunae Cho; Seunho Jung
Journal:  Molecules       Date:  2018-01-02       Impact factor: 4.411

5.  Formulation and evaluation of fixed-dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release.

Authors:  Sanjay Dey; Sankha Chattopadhyay; Bhaskar Mazumder
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.